Journal for ImmunoTherapy of Cancer (Nov 2020)
711 HBM1022, a novel anti-CCR8 antibody depletes tumor-infiltrating regulatory T cells via enhanced ADCC activity, mediates potent anti-tumor activity with Keytruda
- Yun He,
- Juan Liu,
- Fei Chen,
- Yang Cao,
- Yuntao Wu,
- Lei Niu,
- Shuang Lu,
- Shaoping Hu,
- Xin Gan,
- Yongqiang Wang,
- Chuchu Zhao,
- Yi Ding,
- Jinqiu He,
- Qing Du,
- Xiaocheng Lv,
- Beibei Qin,
- Yuandong Wang,
- Yunxing Yang,
- Musheng Bao,
- Jason Noon,
- Wenhao Yu,
- Joe Zhao,
- Yiping Rong
Affiliations
- Yun He
- Harbour Biomed, Shanghai, China
- Juan Liu
- Harbour Biomed, Shanghai, China
- Fei Chen
- Harbour Biomed, Shanghai, China
- Yang Cao
- Harbour Biomed, Shanghai, China
- Yuntao Wu
- Harbour Biomed, Shanghai, China
- Lei Niu
- Harbour Biomed, Shanghai, China
- Shuang Lu
- Harbour Biomed, Shanghai, China
- Shaoping Hu
- Harbour Biomed, Shanghai, China
- Xin Gan
- Harbour Biomed, Shanghai, China
- Yongqiang Wang
- Harbour Biomed, Shanghai, China
- Chuchu Zhao
- Harbour Biomed, Shanghai, China
- Yi Ding
- Harbour Biomed, Shanghai, China
- Jinqiu He
- Harbour Biomed, Shanghai, China
- Qing Du
- Harbour Biomed, Shanghai, China
- Xiaocheng Lv
- Harbour Biomed, Shanghai, China
- Beibei Qin
- Harbour Biomed, Shanghai, China
- Yuandong Wang
- Harbour Biomed, Shanghai, China
- Yunxing Yang
- Harbour Biomed, Shanghai, China
- Musheng Bao
- Harbour Biomed, Shanghai, China
- Jason Noon
- Harbour Biomed, Shanghai, China
- Wenhao Yu
- Harbour Biomed, Shanghai, China
- Joe Zhao
- Harbour Biomed, Shanghai, China
- Yiping Rong
- Harbour Biomed, Shanghai, China
- DOI
- https://doi.org/10.1136/jitc-2020-SITC2020.0711
- Journal volume & issue
-
Vol. 8,
no. Suppl 3
Abstract
No abstracts available.
